Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
BW Businessworld

Dr. Kannan Vishwanatth – A Charismatic Scientist-Entrepreneur

This Business Scientist underpins excellent management and business skills with scientific knowledge, supporting evidence-led decision-making within companies and other enterprises. His ventures are based upon a deep understanding of practice and basic research, as he stands as an internationally recognized expert in his field.

Photo Credit :

1667550485_r7TsPY_Kannan.jpg

This Business Scientist underpins excellent management and business skills with scientific knowledge, supporting evidence-led decision-making within companies and other enterprises. His ventures are based upon a deep understanding of practice and basic research, as he stands as an internationally recognized expert in his field.

An Indian researcher, scholar and entrepreneur Dr. Kannan Vishwanatth studied Bachelor of Petroleum Engineering in the year 1992-1996 from Maharashtra Institute of Technology in Pune, India. He went on to Asia-E-University and Indian Institute of Research and Management India to acquire a Master’s in Business Administration in the year 2008-2009. Dr. Vishwanatth further pursued higher studies from the University of Azteca European Programs and Indian Institute of Research and Management India Doctor of Philosophy in Business Management (2009- 2012). Garwood Innovation Fellow at Garwood Centre of Open Innovation, Haas School of Business Berkeley University of California October 2022 to October 2023.

Having mastered Chemical Engineering, Vishwanatth started his entrepreneurial journey a decade ago and formed a successful mid-sized pharmaceutical company with major thrust on API (Active Pharmaceutical Ingredient).

Rupus Global Limited is an Integrated Pharmaceutical supplier of Intermediates Bulk Drugs and Finished Dosage forms to Emerging Markets founded in 2014. This Pharmaceutical Manufacturing Company has 50 employees Headquartered in Hong Kong.

Dr. Kannan, a 47-year-old visionary is the Founder, Promoter and Managing Director of the Company. Among several other distinguished degrees, he also holds a doctorate in Business Management (Ph.D.).

Dr Kannan is credited with reputation for innovation, social connections, track record for value creation and investor expectations for value creation.

An astute businessman, he has an experience of 20 years in the pharmaceutical industry. As the Promoter & Managing Director, Dr. Vishwanatth, has been the backbone of the Company’s operations and is involved in formulating the Company’s strategy. Under his guidance, the Company, ventured into new geographies with a wide product range in various therapeutic segments. His vision and value system have guided the organization towards profitable sustainability.

Believing in delegation of responsibility, Dr. Vishwanatth created a professional team and expects Rupus Global Limited to emerge as a global player across multiple therapeutic segments.

Dr. Kannan’s dream project is one of the fastest-growing pharmaceutical companies with leadership position in active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and provides contract research and manufacturing services (CRAMS) in key segments such as Anti-Inflammatory, Anti-Protozoal, Anti-Diabetic, Vitamins, Anti-Malarial, Anti-Cancer has set out an ambitious goal to boost its revenue for 225 million USD by 2023-24.

To accelerate its growth engine by revenue & global expansion, Dr. Kannan is exploring new partnerships in Africa & UAE to launch about 50 products in the next 12 months - from Anti-Malarial drugs to pain management and Anti-Cancer.

(Prof) Dr Kannan Vishwanatth, set out its growth plan and said, "We are actively looking out to explore new partnerships and collaborations in Europe for technology transfer and manufacturing associations in the next 12 months in the key segments of Anti-Malarial drugs, Pain Management and Anti-Cancer to cater to the growing demands of the world market."

"We are already present in more than 75 countries; our aim is to touch 100 companies through research & innovations. We are in advanced stage of negotiations with some of the best institutes and companies. Rupus Global Limited will soon be making its presence felt in the United States and we will soon be having an office there.

This highly successful and acclaimed personality has not only won awards for his scientific genius but has taken his business ventures to new unparallel heights. Rupus Global Limited has received Global Health & Pharmaceutical (GHP) Award for the Best Emerging Pharmaceutical Company.

Dr. Kannan tirelessly strives to set new benchmarks in all his endeavours.


Tags assigned to this article: